Uncategorized

Featured image for “<strong>Starkey Partners with Special Olympics International to Bring Hearing Health Services to Athletes in Puerto Rico</strong>”
Nov. 14, 2022

Starkey Partners with Special Olympics International to Bring Hearing Health Services to Athletes in Puerto Rico

HHTM
No excerpt
Featured image for “<strong>Dr. David Akbari Receives Prestigious ADA Hearing Industry Leadership Award</strong>”
Nov. 14, 2022

Dr. David Akbari Receives Prestigious ADA Hearing Industry Leadership Award

HHTM
No excerpt
Featured image for “<strong>Tobias Bartels: EUHA’s new Managing Director</strong>”
Nov. 14, 2022

Tobias Bartels: EUHA’s new Managing Director

HHTM
At the beginning of November, Tobias Bartels took up his new position as the European Union of Hearing Aid Acousticians’ new managing director. The 48-year-old business graduate brings to bear more than 25 years of experience from positions held in international companies in a wide variety of industries. His main focus has been in the fields of marketing and sales, digitization, conventions
Featured image for “Researchers Find Undetectable Low Frequency Sounds Increased Dancing at Live Concert”
Nov. 13, 2022

Researchers Find Undetectable Low Frequency Sounds Increased Dancing at Live Concert

HHTM
HAMILTON, ONTARIO — Researchers studying how different aspects of music influence the body turned a live electronic music concert into a lab study. By introducing levels of bass over speakers that were too low to hear and monitoring the crowd’s movements, scientists found that people danced 11.8 percent more when the very low frequency bass was present. The study appears Monday
Featured image for “Signia Holds National Sales Meeting; Helps Raise Thousands for Charity”
Nov. 11, 2022

Signia Holds National Sales Meeting; Helps Raise Thousands for Charity

HHTM
PISCATAWAY, NEW JERSEY — Capping a year of highly successful new product and program introductions,  Signia took the stage before 150+ attendees at its 2022 National Sales Meeting from October 10 – 13 at JW Marriott Orlando, Grande Lakes and pledged to continue the momentum in 2023 by providing partners and patients with a ‘Brilliant Fit’ that goes beyond innovative
Featured image for “Convey Health Solutions Announces Partnership with Birdsong Hearing Benefits™”
Nov. 10, 2022

Convey Health Solutions Announces Partnership with Birdsong Hearing Benefits™

HHTM
JACKSONVILLE, FLORIDA — Birdsong Hearing Benefits™ has announced a partnership with Convey Health Solutions to serve as its preferred hearing benefits manager. Convey, based in Ft. Lauderdale, Fla., is a leading provider of technology and services to support healthcare organizations and individuals in the Medicare markets. Through this partnership Birdsong will deliver hearing benefit services as a third-party administrator. These services
Featured image for “Frequency Therapeutics Provides Business Updates and Q3 2022 Financial Results”
Nov. 09, 2022

Frequency Therapeutics Provides Business Updates and Q3 2022 Financial Results

HHTM
LEXINGTON, MASSACHUSSETTS — Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced business updates and financial results for the third quarter ended September 30, 2022. “This past quarter has been one of momentum and execution. With the completion of enrollment for the Phase 2b
Featured image for “Signia to Hold Second Virtual Student Event”
Nov. 09, 2022

Signia to Hold Second Virtual Student Event

HHTM
PISCATAWAY, NEW JERSEY – Signia today announced that it is holding its second virtual Signia Student University (SSU) event, featuring several in-depth and interactive sessions that deliver key insights and knowledge for audiology doctorate program students. The free program will kick-off with a live welcome event on December 6th at 6:00 pm ET led by Mike O’Neil, President of Signia
Featured image for “Decibel Therapeutics Announces Submission of Clinical Trial Applications for Lead Gene Therapy Candidate DB-OTO”
Nov. 08, 2022

Decibel Therapeutics Announces Submission of Clinical Trial Applications for Lead Gene Therapy Candidate DB-OTO

HHTM
BOSTON, MASSACHUSSETTS — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, has announced the submission of Clinical Trial Applications (CTAs) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom and the Spanish Agency of Medicines and Medical Devices (AEMPS) for a Phase
Featured image for “FDA Grants Rare Pediatric Disease Designation to Sensorion’s OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss”
Nov. 07, 2022

FDA Grants Rare Pediatric Disease Designation to Sensorion’s OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss

HHTM
MONTPELLIER, FRANCE — Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, announces that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to the Company’s lead therapy gene candidate, OTOF-GT, a gene therapy intended for the treatment of otoferlin